🔎 Trials Near Me

Home › Overactive Bladder › Illinois

Pag-aaral pangklinika para sa Overactive Bladder sa Illinois

8 pag-aaral para sa Overactive Bladder ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

  • University of Chicago, Chicago
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06789406

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

  • Comprehensive Urologic, Barrington
Nagre-recruit
Edad 21 pataas · Kababaihan · Na-update Hul 13, 2026 · NCT07195656

Zinc Supplementation With Botulinum Toxin for Overactive Bladder

  • Endeavor Health, Skokie
Nagre-recruitPhase 2
Edad 21 hanggang 100 · Kababaihan · Na-update Hul 2, 2026 · NCT07405554

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

  • Northwestern Medicine, Chicago
Nagre-recruitPhase 2/3
Edad 18 hanggang 89 · Kalalakihan · Na-update Hun 4, 2026 · NCT05878951

Percutaneous Nerve Evaluation Trial Time

  • University of Chicago, Chicago
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Kababaihan · Na-update Peb 9, 2026 · NCT06226220

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

  • University of Chicago Medicine Urogynecology, Chicago
Nagre-recruit
Edad 22 hanggang 80 · Kababaihan · Na-update Ene 30, 2026 · NCT07209397

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

  • Rush University, Chicago
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT05685433

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

  • University of Chicago, Chicago
Nagre-recruit
Edad 22 pataas · Kababaihan · Na-update Okt 27, 2025 · NCT06797245

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.